Low-frequency electroacupuncture and physical exercise decrease high muscle sympathetic nerve activity in polycystic ovary syndrome
Elisabet Stener-Victorin, Elizabeth Jedel, Per Olof Janson, Yrsa Bergmann Sverrisdottir, Elisabet Stener-Victorin, Elizabeth Jedel, Per Olof Janson, Yrsa Bergmann Sverrisdottir
Abstract
We have recently shown that polycystic ovary syndrome (PCOS) is associated with high muscle sympathetic nerve activity (MSNA). Animal studies support the concept that low-frequency electroacupuncture (EA) and physical exercise, via stimulation of ergoreceptors and somatic afferents in the muscles, may modulate the activity of the sympathetic nervous system. The aim of the present study was to investigate the effect of these interventions on sympathetic nerve activity in women with PCOS. In a randomized controlled trial, 20 women with PCOS were randomly allocated to one of three groups: low-frequency EA (n = 9), physical exercise (n = 5), or untreated control (n = 6) during 16 wk. Direct recordings of multiunit efferent postganglionic MSNA in a muscle fascicle of the peroneal nerve before and following 16 wk of treatment. Biometric, hemodynamic, endocrine, and metabolic parameters were measured. Low-frequency EA (P = 0.036) and physical exercise (P = 0.030) decreased MSNA burst frequency compared with the untreated control group. The low-frequency EA group reduced sagittal diameter (P = 0.001), while the physical exercise group reduced body weight (P = 0.004) and body mass index (P = 0.004) compared with the untreated control group. Sagittal diameter was related to MSNA burst frequency (Rs = 0.58, P < 0.005) in the EA group. No correlation was found for body mass index and MSNA in the exercise group. There were no differences between the groups in hemodynamic, endocrine, and metabolic variables. For the first time we demonstrate that low-frequency EA and physical exercise lowers high sympathetic nerve activity in women with PCOS. Thus, treatment with low-frequency EA or physical exercise with the aim to reduce MSNA may be of importance for women with PCOS.
Source: PubMed
即将进行的临床试验
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)招聘中
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); GlaxoSmithKline; Genentech, Inc.; Brain Science Foundation招聘中
-
National Heart, Lung, and Blood Institute (NHLBI)招聘中
-
National Heart, Lung, and Blood Institute (NHLBI)George Washington University招聘中
-
National Institute of Allergy and Infectious Diseases...招聘中
-
Merck Sharp & Dohme LLC招聘中冯·希佩尔-林道病 | 胰腺神经内分泌肿瘤 | 嗜铬细胞瘤/副神经节瘤 | 晚期胃肠道间质瘤 | HIF-2α 突变癌症美国, 法国, 匈牙利, 意大利, 西班牙, 以色列, 英国, 荷兰, 澳大利亚, 新加坡, 日本, 中国, 加拿大, 德国, 葡萄牙, 俄罗斯, 瑞典, 土耳其(türkiye), 挪威, 智利, 丹麦, 韩国
-
Johnson & Johnson Enterprise Innovation Inc.招聘中癌,鳞状细胞美国, 台湾, 奥地利, 英国, 法国, 日本, 巴西, 中国, 西班牙, 比利时, 印度, 塞尔维亚, 德国, 保加利亚, 以色列, 克罗地亚, 匈牙利, 乔治亚州, 葡萄牙, 希腊, 韩国, 瑞典, 捷克语, 菲律宾, 加拿大, 芬兰, 罗马尼亚